Considering the reported influence of oncogene mutations on CRC and RC recurrence, we also examined the mutational status of key CRC‐related oncogenes (KRAS, NRAS, BRAF, and PIK3CA) and investigated their correlation with LR. This evidence concerns the gene KRAS and colorectal carcinoma.